Ashish Gupta, MBBS, MPH
Masonic Cancer Center, University of Minnesota
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ashish Gupta, MBBS, MPH as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:02 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT02605421 · Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk NeuroblastomaMasonic Cancer Center, University of Minnesota · recruiting · Neuroblastoma · principal investigator
- N/ANCT02179359 · Hematopoietic Stem Cell Transplant for High Risk HemoglobinopathiesMasonic Cancer Center, University of Minnesota · terminated · Sickle Cell Disease, Transfusion Dependent Alpha- or Beta- Thalassemia, Diamond Blackfan Anemia · principal investigator
- N/ANCT01526603 · High Dose Chemotherapy and Autologous Transplant for NeuroblastomaMasonic Cancer Center, University of Minnesota · completed · Neuroblastoma · principal investigator
- N/ANCT01505569 · Auto Transplant for High Risk or Relapsed Solid or CNS TumorsMasonic Cancer Center, University of Minnesota · completed · Ewing's Family Tumors, Renal Tumors, Hepatoblastoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in neuroblastoma.